IMP
Process View
fibroblast proliferation
The multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "fibroblast proliferation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RING1 | ring finger protein 1 | 0.998 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.997 | ||
| VEGFA | vascular endothelial growth factor A | 0.994 | Human | |
| RNF2 | ring finger protein 2 | 0.981 | ||
| RB1 | retinoblastoma 1 | 0.916 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.914 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.895 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.842 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.797 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.737 | Human | |
| CBX7 | chromobox homolog 7 | 0.729 | ||
| CBX8 | chromobox homolog 8 | 0.703 | ||
| FTL | ferritin, light polypeptide | 0.636 | Human | |
| APLF | aprataxin and PNKP like factor | 0.630 | ||
| RYBP | RING1 and YY1 binding protein | 0.620 | ||
| PLAU | plasminogen activator, urokinase | 0.601 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.581 | ||
| CCND1 | cyclin D1 | 0.571 | ||
| CBX6 | chromobox homolog 6 | 0.546 | ||
| DTX3L | deltex 3-like (Drosophila) | 0.520 | ||
| RBL2 | retinoblastoma-like 2 (p130) | 0.501 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.456 | ||
| PARP9 | poly (ADP-ribose) polymerase family, member 9 | 0.436 | Human | |
| PCGF2 | polycomb group ring finger 2 | 0.422 | Human | |
| USP11 | ubiquitin specific peptidase 11 | 0.417 | ||
| FTH1 | ferritin, heavy polypeptide 1 | 0.417 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.407 | ||
| TFDP2 | transcription factor Dp-2 (E2F dimerization partner 2) | 0.400 | ||
| AXL | AXL receptor tyrosine kinase | 0.397 | ||
| TFDP1 | transcription factor Dp-1 | 0.384 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.357 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.348 | ||
| PARP14 | poly (ADP-ribose) polymerase family, member 14 | 0.339 | Human | |
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.334 | Mouse | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.327 | Human | |
| BMI1 | BMI1 polycomb ring finger oncogene | 0.312 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.283 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.282 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.280 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.276 | ||
| E2F1 | E2F transcription factor 1 | 0.256 | ||
| NRP1 | neuropilin 1 | 0.242 | ||
| LIG4 | ligase IV, DNA, ATP-dependent | 0.237 | Mouse | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.212 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.210 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.204 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.188 | ||
| CCND3 | cyclin D3 | 0.183 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.172 | ||
| CBX4 | chromobox homolog 4 | 0.163 | ||
| TFF1 | trefoil factor 1 | 0.142 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.139 | ||
| MAX | MYC associated factor X | 0.135 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.132 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.129 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.128 | ||
| RNF144B | ring finger protein 144B | 0.126 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.117 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.113 | ||
| PCGF5 | polycomb group ring finger 5 | 0.108 | Human | |
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.105 | Rat | |
| TP53 | tumor protein p53 | 0.105 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.099 | ||
| BCOR | BCL6 corepressor | 0.098 | ||
| CTSB | cathepsin B | 0.095 | ||
| E2F4 | E2F transcription factor 4, p107/p130-binding | 0.092 | Human | |
| E2F2 | E2F transcription factor 2 | 0.089 | Human | |
| BAD | BCL2-associated agonist of cell death | 0.088 | ||
| S100B | S100 calcium binding protein B | 0.087 | ||
| E2F6 | E2F transcription factor 6 | 0.082 | Human | |
| CUX1 | cut-like homeobox 1 | 0.082 | ||
| RXRA | retinoid X receptor, alpha | 0.081 | ||
| E2F3 | E2F transcription factor 3 | 0.078 | Human | |
| CCND2 | cyclin D2 | 0.074 | ||
| PDGFC | platelet derived growth factor C | 0.073 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.065 | ||
| CCNE1 | cyclin E1 | 0.065 | ||
| ATF2 | activating transcription factor 2 | 0.065 | ||
| AHR | aryl hydrocarbon receptor | 0.064 | ||
| UQCRB | ubiquinol-cytochrome c reductase binding protein | 0.062 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.061 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.059 | ||
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.059 | ||
| CKS1B | CDC28 protein kinase regulatory subunit 1B | 0.058 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.057 | ||
| JUNB | jun B proto-oncogene | 0.057 | ||
| SIRT1 | sirtuin 1 | 0.055 | ||
| COPS6 | COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis) | 0.053 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.052 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.052 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.051 | ||
| FOSL1 | FOS-like antigen 1 | 0.050 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.050 | ||
| STMN2 | stathmin-like 2 | 0.047 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.047 | ||
| COL11A2 | collagen, type XI, alpha 2 | 0.046 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.045 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.045 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.045 | ||
| LGALS8 | lectin, galactoside-binding, soluble, 8 | 0.044 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.044 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.043 | ||
| PCGF3 | polycomb group ring finger 3 | 0.042 | Human | |
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.042 | ||
| MED16 | mediator complex subunit 16 | 0.042 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.041 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.041 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.040 | ||
| PCGF1 | polycomb group ring finger 1 | 0.039 | Human | |
| KITLG | KIT ligand | 0.039 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.039 | ||
| ALK | anaplastic lymphoma receptor tyrosine kinase | 0.038 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.037 | ||
| SATB2 | SATB homeobox 2 | 0.037 | ||
| PURA | purine-rich element binding protein A | 0.037 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.036 | Human Rat | |
| APRT | adenine phosphoribosyltransferase | 0.036 | ||
| LIN9 | lin-9 homolog (C. elegans) | 0.036 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.036 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.035 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.034 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.034 | ||
| DCN | decorin | 0.034 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.034 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.033 | ||
| NMI | N-myc (and STAT) interactor | 0.033 | ||
| CTBP2 | C-terminal binding protein 2 | 0.032 | ||
| ATF3 | activating transcription factor 3 | 0.030 | ||
| SMAD4 | SMAD family member 4 | 0.030 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.030 | ||
| FAM118B | family with sequence similarity 118, member B | 0.030 | ||
| ADM | adrenomedullin | 0.030 | ||
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.030 | ||
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.029 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.028 | ||
| NHEJ1 | nonhomologous end-joining factor 1 | 0.028 | ||
| TP73 | tumor protein p73 | 0.028 | Human | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.027 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.027 | Human | |
| IL8 | interleukin 8 | 0.027 | ||
| C1D | C1D nuclear receptor corepressor | 0.026 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.026 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.025 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.024 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.024 | ||
| YAF2 | YY1 associated factor 2 | 0.024 | ||
| RNR2 | l-rRNA | 0.024 | ||
| ZNF267 | zinc finger protein 267 | 0.024 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.024 | ||
| FGF3 | fibroblast growth factor 3 | 0.024 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.024 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.023 | ||
| NDUFB5 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa | 0.023 | ||
| ZBTB45 | zinc finger and BTB domain containing 45 | 0.023 | ||
| WASF1 | WAS protein family, member 1 | 0.023 | ||
| CD63 | CD63 molecule | 0.023 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.023 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.023 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.023 | ||
| RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.023 | ||
| ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F | 0.022 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.022 | ||
| THBS1 | thrombospondin 1 | 0.022 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.022 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.022 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.021 | ||
| ESRRG | estrogen-related receptor gamma | 0.021 | ||
| IFRD1 | interferon-related developmental regulator 1 | 0.021 | ||
| TCP10L | t-complex 10 (mouse)-like | 0.021 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.021 | ||
| BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0.021 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.021 | ||
| JUN | jun proto-oncogene | 0.020 | Mouse | |
| STAB1 | stabilin 1 | 0.020 | ||
| NLK | nemo-like kinase | 0.020 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.020 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.020 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.020 | ||
| KLF6 | Kruppel-like factor 6 | 0.019 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.019 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.019 | ||
| CTSL1 | cathepsin L1 | 0.019 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.019 | ||
| HDAC2 | histone deacetylase 2 | 0.019 | ||
| THBS2 | thrombospondin 2 | 0.019 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.019 | ||
| HMOX1 | heme oxygenase (decycling) 1 | 0.019 | ||
| AQP5 | aquaporin 5 | 0.019 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.018 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.018 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.018 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.018 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.018 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.018 | ||
| PEX19 | peroxisomal biogenesis factor 19 | 0.018 | ||
| PNKP | polynucleotide kinase 3'-phosphatase | 0.017 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.017 | ||
| HIC1 | hypermethylated in cancer 1 | 0.017 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.017 | ||
| CMIP | c-Maf-inducing protein | 0.017 | ||
| LAT | linker for activation of T cells | 0.017 | ||
| BNIP2 | BCL2/adenovirus E1B 19kDa interacting protein 2 | 0.017 | ||
| PDE9A | phosphodiesterase 9A | 0.017 | ||
| KRT6C | keratin 6C | 0.017 | ||
| LAP3 | leucine aminopeptidase 3 | 0.017 | ||
| S1PR5 | sphingosine-1-phosphate receptor 5 | 0.017 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.017 | Human | |
| CDK5 | cyclin-dependent kinase 5 | 0.016 | ||
| DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.016 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.016 | ||
| WIF1 | WNT inhibitory factor 1 | 0.016 | ||
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.016 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.016 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.016 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.016 | ||
| MGP | matrix Gla protein | 0.016 | ||
| FRK | fyn-related kinase | 0.016 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.016 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.016 | ||
| SELENBP1 | selenium binding protein 1 | 0.016 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.016 | ||
| ABI2 | abl-interactor 2 | 0.016 | ||
| C14orf1 | chromosome 14 open reading frame 1 | 0.016 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.015 | ||
| SERTAD2 | SERTA domain containing 2 | 0.015 | ||
| UBQLN1 | ubiquilin 1 | 0.015 | ||
| PSAP | prosaposin | 0.015 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.015 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.015 | ||
| MMP19 | matrix metallopeptidase 19 | 0.015 | ||
| PCGF6 | polycomb group ring finger 6 | 0.015 | Human | |
| HAP1 | huntingtin-associated protein 1 | 0.015 | ||
| TTR | transthyretin | 0.015 | ||
| PMF1 | polyamine-modulated factor 1 | 0.015 | ||
| A2M | alpha-2-macroglobulin | 0.015 | ||
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.015 | ||
| CD34 | CD34 molecule | 0.015 | ||
| SIK1 | salt-inducible kinase 1 | 0.015 | ||
| TCF4 | transcription factor 4 | 0.015 | ||
| MAP2 | microtubule-associated protein 2 | 0.015 | ||
| PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.015 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.014 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.014 | ||
| IFIH1 | interferon induced with helicase C domain 1 | 0.014 | ||
| CDKN2D | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 0.014 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.014 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.014 | ||
| FGF18 | fibroblast growth factor 18 | 0.014 | ||
| YY1 | YY1 transcription factor | 0.014 | ||
| SAMD9L | sterile alpha motif domain containing 9-like | 0.014 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.014 | ||
| MED26 | mediator complex subunit 26 | 0.014 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.014 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.014 | ||
| ORM1 | orosomucoid 1 | 0.014 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.013 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.013 | ||
| CACNB4 | calcium channel, voltage-dependent, beta 4 subunit | 0.013 | ||
| TNXB | tenascin XB | 0.013 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.013 | ||
| PIGA | phosphatidylinositol glycan anchor biosynthesis, class A | 0.013 | ||
| SKIL | SKI-like oncogene | 0.013 | ||
| HMOX2 | heme oxygenase (decycling) 2 | 0.013 | ||
| TRIM5 | tripartite motif containing 5 | 0.013 | ||
| PPP1R13B | protein phosphatase 1, regulatory (inhibitor) subunit 13B | 0.013 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.013 | ||
| PTN | pleiotrophin | 0.013 | ||
| INSR | insulin receptor | 0.013 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.013 | ||
| UNC119 | unc-119 homolog (C. elegans) | 0.013 | ||
| BGN | biglycan | 0.013 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.013 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.013 | Mouse | |
| DCP1A | DCP1 decapping enzyme homolog A (S. cerevisiae) | 0.013 | ||
| NME4 | non-metastatic cells 4, protein expressed in | 0.013 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.013 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.013 | ||
| PIM1 | pim-1 oncogene | 0.013 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.013 | ||
| TRAP1 | TNF receptor-associated protein 1 | 0.013 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.012 | ||
| CCNDBP1 | cyclin D-type binding-protein 1 | 0.012 | ||
| TBK1 | TANK-binding kinase 1 | 0.012 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.012 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.012 | ||
| FATE1 | fetal and adult testis expressed 1 | 0.012 | ||
| MPG | N-methylpurine-DNA glycosylase | 0.012 | ||
| PLAT | plasminogen activator, tissue | 0.012 | ||
| RBMS1 | RNA binding motif, single stranded interacting protein 1 | 0.012 | ||
| CRELD2 | cysteine-rich with EGF-like domains 2 | 0.012 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.012 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.012 | ||
| RARA | retinoic acid receptor, alpha | 0.012 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.012 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.012 | ||
| FIBP | fibroblast growth factor (acidic) intracellular binding protein | 0.012 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.012 | ||
| PRRX1 | paired related homeobox 1 | 0.012 | ||
| BCL2L2 | BCL2-like 2 | 0.012 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.012 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.012 | ||
| HBP1 | HMG-box transcription factor 1 | 0.012 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.012 | ||
| TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | 0.012 | ||
| AES | amino-terminal enhancer of split | 0.012 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.012 | ||
| IHH | Indian hedgehog | 0.012 | ||
| SOCS6 | suppressor of cytokine signaling 6 | 0.012 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.012 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.012 | ||
| VCAN | versican | 0.012 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.012 | ||
| PAX5 | paired box 5 | 0.012 | ||
| NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | 0.012 | ||
| PSMD10 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 | 0.012 | ||
| FERMT2 | fermitin family member 2 | 0.012 | ||
| PGF | placental growth factor | 0.012 | Human | |
| CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) | 0.012 | ||
| RNF40 | ring finger protein 40 | 0.012 | ||
| GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 0.012 | ||
| INHBA | inhibin, beta A | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | ||
| FGF4 | fibroblast growth factor 4 | 0.012 | ||
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.012 | ||
| ZNF676 | zinc finger protein 676 | 0.012 | ||
| ANGPT2 | angiopoietin 2 | 0.011 | ||
| HNRNPCL1 | heterogeneous nuclear ribonucleoprotein C-like 1 | 0.011 | ||
| NOV | nephroblastoma overexpressed gene | 0.011 | ||
| PLXDC1 | plexin domain containing 1 | 0.011 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.011 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.011 | ||
| FASTK | Fas-activated serine/threonine kinase | 0.011 | ||
| FZD2 | frizzled homolog 2 (Drosophila) | 0.011 | ||
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.011 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.011 | ||
| MAN1B1 | mannosidase, alpha, class 1B, member 1 | 0.011 | ||
| ELN | elastin | 0.011 | ||
| CDK14 | cyclin-dependent kinase 14 | 0.011 | ||
| PYCARD | PYD and CARD domain containing | 0.011 | ||
| FNDC3A | fibronectin type III domain containing 3A | 0.011 | ||
| RALGDS | ral guanine nucleotide dissociation stimulator | 0.011 | ||
| NME2 | non-metastatic cells 2, protein (NM23B) expressed in | 0.011 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.011 | ||
| ND1 | NADH dehydrogenase, subunit 1 (complex I) | 0.011 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.011 | ||
| BTRC | beta-transducin repeat containing | 0.011 | ||
| CRYAB | crystallin, alpha B | 0.011 | ||
| S100A1 | S100 calcium binding protein A1 | 0.011 | ||
| ERBB2IP | erbb2 interacting protein | 0.011 | ||
| ABI1 | abl-interactor 1 | 0.011 | ||
| GFER | growth factor, augmenter of liver regeneration | 0.011 | ||
| BLZF1 | basic leucine zipper nuclear factor 1 | 0.011 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.011 | ||
| CTSH | cathepsin H | 0.011 | ||
| STC1 | stanniocalcin 1 | 0.011 | ||
| MGST3 | microsomal glutathione S-transferase 3 | 0.011 | ||
| LIN54 | lin-54 homolog (C. elegans) | 0.011 | ||
| TRIM8 | tripartite motif containing 8 | 0.011 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.011 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.011 | ||
| SPRR2A | small proline-rich protein 2A | 0.011 | ||
| EDN1 | endothelin 1 | 0.011 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.011 | ||
| PSEN1 | presenilin 1 | 0.011 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.011 | ||
| DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.011 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.011 | ||
| SMAD9 | SMAD family member 9 | 0.011 | ||
| C1orf9 | chromosome 1 open reading frame 9 | 0.010 | ||
| ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 0.010 | ||
| PEX16 | peroxisomal biogenesis factor 16 | 0.010 | ||
| MUC1 | mucin 1, cell surface associated | 0.010 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.010 | ||
| CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 0.010 | ||
| TRMT2A | TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae) | 0.010 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.010 | ||
| TF | transferrin | 0.010 | ||
| IER5 | immediate early response 5 | 0.010 | ||
| NGFR | nerve growth factor receptor | 0.010 | Mouse | |
| LY86 | lymphocyte antigen 86 | 0.010 | ||
| MYLK | myosin light chain kinase | 0.010 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.010 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.010 | ||
| BTG3 | BTG family, member 3 | 0.010 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.010 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.010 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.010 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.010 | ||
| SPP1 | secreted phosphoprotein 1 | 0.010 | ||
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0.010 |